Figure 2. Docking of A, gingerenone B at the active site of 1H30; B, procyanidin B1 at the active site of 1NQL; C, astragalin at the active site of 1UA2; D, kushenol E at the active site of 2WWZ, and Quercetin-3-o-galactopyranoside at the active site of; E, 2X1N and; F, 2XA0 respectively.